{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:02:00Z","timestamp":1763766120142},"reference-count":51,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:00:00Z","timestamp":1402531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:00:00Z","timestamp":1402531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World j. surg."],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This paper reviews the role of low\u2010grade dysplasia (LGD) as a marker of progression in Barrett\u2019s oesophagus (BO). Albeit with its limits due to the difficulty of its diagnosis and the low agreement among pathologists, LGD remains the most relevant single prognostic factor of progression, and, when the diagnosis is confirmed by two or three pathologists, the chances of progression to high\u2010grade dysplasia or invasive adenocarcinoma are as high as 40 %. On the other hand, BO patients who remain dysplasia free at several follow\u2010up examinations seem to have a very low likelihood of progression. The diagnosis of LGD should be confirmed by two pathologists, and surveillance programs should be tailored depending on the presence or persistent absence of LGD. Ablative therapy should be also considered for cases where LGD persists in a series of follow\u2010ups.<\/jats:p>","DOI":"10.1007\/s00268-014-2661-5","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T17:35:14Z","timestamp":1402508114000},"page":"578-585","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Surveillance for Low\u2010Grade Dysplastic Barrett\u2019s Oesophagus: One Size Fits All?"],"prefix":"10.1002","volume":"39","author":[{"given":"Giovanni","family":"Zaninotto","sequence":"first","affiliation":[{"name":"Department of Surgery and Cancer, St Mary\u2019s Hospital Imperial College London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Bennett","sequence":"additional","affiliation":[{"name":"Evidence Based Medicine, Faculty of Medicine University of Plymouth Plymouth UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,6,12]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.130"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103042"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.028076"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.01.031"},{"key":"e_1_2_6_6_2","first-page":"3673","article-title":"Cancer of the esophagus and of the esophagogastric junction. Data\u2010driven staging for the seventh edition of the American Joint Committee on Cancer\/International Union Against Cancer Staging Manual","volume":"116","author":"Ryce TW","year":"2010","journal-title":"Cancer"},{"key":"e_1_2_6_7_2","first-page":"CD007334","article-title":"Surgery versus radical endotherapies for early cancer and high\u2010grade dysplasia in Barrett\u2019s oesophagus","volume":"11","author":"Bennett C","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572\u20100241.2008.01835.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2012.08.004"},{"key":"e_1_2_6_10_2","unstructured":"British Society of Gastroenterology (BSG). BSG guidelines for the diagnosis and management of columnar lined oesophagus. A report of the working party of the British Society of Gastroenterology.http:\/\/www.bsg.org.uk\/pdf_word_docs\/Barretts_Oes.pdf. Accessed 08 June 2014"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl\u20102013\u2010305372"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20102007\u2010966653"},{"key":"e_1_2_6_13_2","first-page":"840","article-title":"Upper endoscopy for gastroesophageal reflux disease: best practice advice from the Clinical Guidelines Committee of the American College of Physicians","volume":"39","author":"Shaheen NJ","year":"2012","journal-title":"Ann Intern Med"},{"key":"e_1_2_6_14_2","unstructured":"ThomsonS FoubisterT MossialosE(2009)Financing health care in the European Union: challenges and policy responses.www.euro.who.int\/__data\/assets\/pdf_file\/0009\/98307\/E92469.pdf. Accessed 15 Jan 2014"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003\u20104819\u2010138\u20103\u2010200302040\u201000009"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta10080"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e328353d58e"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.9.1155"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.2"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.2.251"},{"key":"e_1_2_6_21_2","first-page":"34","article-title":"Prevalence of adenocarcinoma at esophagectomy for Barrett\u2019s esophagus with high\u2010grade dysplasia","volume":"2","author":"Nasr JY","year":"2011","journal-title":"J Surg Oncol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2007.07.019"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.032"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.05.040"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102559.2009.03316.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20102007\u2010966592"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182737a7e"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.31"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr203"},{"key":"e_1_2_6_30_2","first-page":"566","volume":"4","author":"Sharma G","year":"2006","journal-title":"Dysplasia and cancer in a large multicentre cohort of patients with Barrett\u2019s esophagus Clin Gastroenterol Hepathol"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.055"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000194085.56699.db"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.09.006"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102559.2007.02706.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102559.2009.03288.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2011\u20100019\u2010RA"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102559.2010.03571.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.171"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572\u20100241.2000.03348.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572\u20100241.2007.01073.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25111"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.4.486"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.5858\/2010-0097-OA.1"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737\u2010200509000\u201000010"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.11.008"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn121"},{"key":"e_1_2_6_47_2","first-page":"5","article-title":"Low prevalence of invasive adenocarcinoma and occult cancer on esophaheal resection for Barrett\u2019s Esophagus with high grade dysplasia; evidence for a conservative management","volume":"2","author":"Patil DT","year":"2011","journal-title":"J Gastrointest Oncol"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02196.x"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2001.23510"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u2010230X\u201010\u2010111"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808145"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.05.010"}],"container-title":["World Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00268-014-2661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00268-014-2661-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s00268-014-2661-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T23:23:09Z","timestamp":1703632989000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s00268-014-2661-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,12]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.1007\/s00268-014-2661-5"],"URL":"https:\/\/doi.org\/10.1007\/s00268-014-2661-5","archive":["Portico"],"relation":{},"ISSN":["0364-2313","1432-2323"],"issn-type":[{"value":"0364-2313","type":"print"},{"value":"1432-2323","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,12]]}}}